Objective response by RECIST | Test value* | P value | Sig. | ||||
---|---|---|---|---|---|---|---|
CMR | PMR | SMD | PMD | ||||
No. = 8 | No. = 18 | No. = 3 | No. = 4 | ||||
Pathology | |||||||
NHL | 3 (37.5%) | 9 (50.0%) | 0 (0.0%) | 3(75.0%) | 5.435 | 0.489 | NS |
HL | 5 (62.5%) | 8 (44.4%) | 3 (100.0%) | 1 (25.0%) | |||
GALT | 0 (0.0%) | 1 (5.6%) | 0 (0.0%) | 0 (0.0%) | |||
Location | |||||||
NA | 1 (12.5%) | 2 (11.1%) | 0 (0.0%) | 1 (25.0%) | 10.530 | 0.104 | NS |
Supra | 6 (75.0%) | 5 (27.8%) | 3 (100.0%) | 1 (25.0%) | |||
Supra & infra | 1 (12.5%) | 11 (61.1%) | 0 (0.0%) | 2 (50.0%) | |||
Stage | |||||||
I | 1 (12.5%) | 1 (5.6%) | 0 (0.0%) | 0 (0.0%) | 26.203 | 0.095 | NS |
IE | 1 (12.5%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |||
II | 4 (50.0%) | 4 (22.2%) | 3 (100.0%) | 0 (0.0%) | |||
IIE | 1 (12.5%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |||
III | 0 (0.0%) | 3 (16.7%) | 0 (0.0%) | 2 (50.0%) | |||
IIIS | 1 (12.5%) | 6 (33.3%) | 0 (0.0%) | 0 (0.0%) | |||
IV | 0 (0.0%) | 4 (22.2%) | 0 (0.0%) | 2 (50.0%) | |||
New lesion | |||||||
Absent | 8 (100.0%) | 18 (100%) | 3 (100.0%) | 0 (0.0%) | 33.000 | 0.000 | HS |
Present | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 4 (100.0%) |